Pamela Keck

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

Part of Prudential Financial, Inc., Prudential Investment Corp. provides investment advice. The company is based in Grass Lake, MI.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

IsoTis SA develops biomedical products. Its product include proprietary natural and synthetic bone graft substitutes and other related medical devices. These devices are used to enhance the repair and regeneration of bone in spinal and trauma surgery, joint replacements and dental applications. IsoTis' products are primarily used spinal fusion, trauma, joint revision, bone void filling and iliac crest backfills procedures. The company is headquartered in Lausanne, Switzerland.

MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA.

Part of Novartis AG, Chiron Behring & Co. is a German company that supplies and develops new vaccine products for adults and children. The company is based in Marburg, Germany. Chiron Behring was acquired by Chiron Corp. from Hoechst AG on April 01, 1998 for $111.90 million.

Allergan Ltd. provides eye care and specialty pharmaceutical products. It develops pharmaceutical products used for treatment of eye and skin care medications and neurological disorders. The firm develops products for glaucoma, dry eye, blepharospasm, cervical, dystonia, hemi-facial spasm, post-stroke spasticity and cerebral palsy. The company was founded in 1977 and is headquartered in Marlow, the United Kingdom.

AMGEN GmbH develops, manufactures, and markets human therapeutics based on cellular biology. It was established to help sell and distribute biotechnical therapies for the treatment of such ailments as chemotherapy side effects, chronic kidney failure, and rheumatoid arthritis. Among the group's products are Epogen & Aranesp for the treatment of anemia in people with chronic kidney disease; Neupogen & Neulasta to help restore white blood cell counts for cancer patients and Enbrel for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 1980 and is headquartered in Munich, Germany.

Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany.

Dr. Rentschler Holding GmbH & Co. KG operates as a holding company with interests in pharmaceutical research and production. Its services include project management, cell line and process developing, as well as analytics and quality controlling solutions. The company was founded in 1927 and is headquartered in Laupheim, Germany.

Sensimed SA develops non-invasive soft contact lens-based solutions. It offers solutions to monitor fluctuations in intraocular pressure continuously. The company was founded by Matteo Leonardi and Sacha Cerboni in 2003 and is headquartered in Lausanne, Switzerland.

EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy.

H3 AEROSPACE GmbH & Co. KG engages in the acquisition, manufacture, marketing, leasing and sale of airplanes. The company was founded by Antoinette Hiebeler-Hasner in 2006 and is headquartered in Tussenhausen-Mattsies, Germany.

The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution.

Catherex, Inc. provides medical research services. The company was founded by Michael A. Christini and is headquartered in Philadelphia, PA.

MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. develops and researches vaccines. The joint venture company is based in Gurgaon, India. The company was founded in 2009. Raman Rao has been the CEO of the Indian company since 2020.

Part of Vistra Group Ltd., Vistra GmbH & Co. KG Wirtschaftsprüfungsgesellschaft is a company based in Cologne, Germany. The German company specializes in helping investments grow and succeed internationally, providing investment and transaction services. The company has experts in fund services and private equity who can navigate local regulations and nuances in over 45 jurisdictions throughout the funds lifecycle. The company was founded in 2009 and has Kerstin Bors, Joachim Buchau, and Peter Lenz as CEOs. Vistra GmbH & Co. KG Wirtschaftsprüfungsgesellschaft was acquired by Vistra SA on April 03, 2017.

Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million.

leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany.

Ventuz Technology AG provides software solutions for authoring and displaying real-time interactive, data-driven graphics to markets with high-end requirements. The private company is based in Hamburg, Germany. The German company's products, Ventuz Designer, Director, and Runtime, are based on DirectX and Microsoft .NET and are compatible with MS Windows systems only. The company also offers a Ventuz and Substance integration for both Substance products: Substance Designer and Substance Painter. The company was founded in 2004. The CEO is Ralf Stanke.

Optegra Holding GmbH provides auditing and tax consulting services. The private company is based in Cologne, Germany.

Part of H3 AEROSPACE GmbH & Co. KG, Grob Aircraft SE is a German company that manufactures and sells aircrafts. The company is based in Tussenhausen-Mattsies, Germany. The company was founded in 1971. The CEO is André Hiebeler.

Vistra Gmbh & Co. Kg is a business entity that specializes in collateral and CLO administration, complex and executive service contracts, operational and business tax leakage assessment, and family business. The private company is based in Cologne, Germany. The German company prioritizes building strong and trusted connections with their clients by deeply understanding their professional worlds, which is drawn from their extensive experience in finance, structuring, law, and accounting. The company is committed to doing the right thing for their colleagues, clients, communities, and the future of the planet.

Part of Dr. Rentschler Holding GmbH & Co. KG, Rentschler Biotechnologie Beteiligungs GmbH is a German company that provides investment services. The company is based in Laupheim, Germany. The CEOs of the company are Jürgen Müller, Nikolaus Friedrich Rentschler.

Kidpharma AG manufactures pharmaceutical products. The private company is based in Root, Switzerland.

LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany.